HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stefanie Gross Selected Research

Brain Neoplasms (Brain Tumor)

11/2017ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stefanie Gross Research Topics

Disease

13Neoplasms (Cancer)
01/2019 - 02/2008
10Melanoma (Melanoma, Malignant)
03/2024 - 09/2013
2Infections
03/2024 - 01/2019
2Neoplasm Metastasis (Metastasis)
06/2021 - 11/2017
2Bites and Stings (Sting)
06/2021 - 11/2017
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 11/2014
2Injection Site Reaction
04/2017 - 04/2014
1Chondrosarcoma
03/2024
1Squamous Cell Carcinoma of Head and Neck
03/2024
1Leukemia
01/2019
1Skin Neoplasms (Skin Cancer)
01/2018
1Hemorrhage
11/2017
1Brain Neoplasms (Brain Tumor)
11/2017
1Meningioma (Meningiomas)
11/2017
1Necrosis
11/2017
1Glioma (Gliomas)
11/2017
1Eosinophilia
04/2017
1Renal Cell Carcinoma (Grawitz Tumor)
11/2014
1Hepatocellular Carcinoma (Hepatoma)
11/2014
1Carcinogenesis
01/2002

Drug/Important Bio-Agent (IBA)

6VaccinesIBA
09/2017 - 05/2009
3Neoplasm Antigens (Tumor Antigens)IBA
01/2019 - 09/2013
3Proteins (Proteins, Gene)FDA Link
01/2018 - 09/2017
3Peptides (Polypeptides)IBA
04/2017 - 04/2014
2talimogene laherparepvecIBA
03/2024 - 06/2021
2InterferonsIBA
06/2021 - 11/2017
2Biomarkers (Surrogate Marker)IBA
06/2021 - 11/2014
2EMD640744IBA
01/2016 - 04/2014
2Monatide (IMS 3015)IBA
01/2016 - 04/2014
2SurvivinIBA
01/2016 - 04/2014
2AntigensIBA
09/2010 - 02/2008
1HMGB1 Protein (HMG1)IBA
03/2024
1Adenosine Triphosphate (ATP)IBA
03/2024
1cyclic guanosine monophosphate-adenosine monophosphateIBA
06/2021
1NectinsIBA
06/2021
1MART-1 AntigenIBA
01/2019
1Interleukin-12 (IL 12)IBA
01/2019
1Immune Checkpoint InhibitorsIBA
01/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018
1A-factor (Streptomyces)IBA
01/2018
1LigandsIBA
01/2018
1Death Domain ReceptorsIBA
01/2018
1TNF-Related Apoptosis-Inducing LigandIBA
01/2018
1vadimezanIBA
11/2017
1Eosine Yellowish-(YS) (Eosin)IBA
11/2017
1CalciumIBA
11/2017
1Caspase 8 (Caspase-8)IBA
11/2017
1MIB-1 antibodyIBA
11/2017
1Hematoxylin (Haematoxylon)IBA
11/2017
1Phosphatidylethanolamine Binding ProteinIBA
09/2017
1raf KinasesIBA
09/2017
1Interleukin-6 (Interleukin 6)IBA
04/2017
1IpilimumabIBA
04/2017
1Dinoprostone (PGE2)FDA Link
04/2017
1Protein Subunit VaccinesIBA
01/2016
1Interleukin-8 (Interleukin 8)IBA
11/2014
1ChemokinesIBA
11/2014
1N 30IBA
11/2014
1Monoclonal AntibodiesIBA
11/2014
1EpitopesIBA
04/2014
1PaxillinIBA
02/2013
1IntegrinsIBA
02/2013
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
02/2008
1Transforming Growth Factor beta (TGF-beta)IBA
01/2002

Therapy/Procedure

4Therapeutics
01/2019 - 11/2014
4Immunotherapy
09/2017 - 02/2008
1Intralesional Injections
06/2021
1Drug Therapy (Chemotherapy)
01/2018